Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
A closer look at OpenAI CEO Sam Altman after President Trump announces a multi-billion dollar joint venture between Altman's company, Softbank and Oracle, and why it's already drawing the ire of major ...
Some results have been hidden because they may be inaccessible to you